Directori de persones
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grau: Doctor/a

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicacions

  • Valdivielso JM; Bozic M; Galimudi RK; Bermudez-López M; Navarro-González JF; Fernández E; Betriu À

    Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 2079-2088. .

    [doi:10.1093/ndt/gfy207]

  • Valdivielso, JM; Rodriguez-Puyol, D; Pascual, J; Barrios, C; Bermudez-Lopez, M; Sanchez-Nino, MD; Perez-Fernandez, M; Ortiz, A

    Atherosclerosis in Chronic Kidney Disease More, Less, or Just Different?

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 39 1938-1966. .

    [doi:10.1161/ATVBAHA.119.312705]

  • Martinez-Lopez, D; Roldan-Montero, R; Garcia-Marques, F; Nunez, E; Jorge, I; Camafeita, E; De Cordoba, SR; Valdivieso, JM; Michel, JB; Blanco-Colio, LM; Vazquez, J; Martin-Ventura, JL

    TOPOLOGICALLY-RESOLVED PROTEOMICS OF EARLY HUMAN ATHEROSCLEROTIC PLAQUES REVEALS COMPLEMENT C5 AS A BIOMARKER OF SUBCLINICAL ATHEROSCLEROSIS

    MOLECULAR IMMUNOLOGY 114 474-474. .

  • Forné, Carles; Cambray, Serafi; Bermudez-Lopez, Marcelino; Fernandez, Elvira; Bozic, Milica; Valdivielso, Jose M

    Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease

    CLINICAL KIDNEY JOURNAL 13 631-639. .

    [doi:10.1093/ckj/sfz094]

  • Palanca, A; Castelblanco, E; Betriu À; Perpiñán H; Soldevila, B; Valdivielso, JM; Bermudez-Lopez, M; Puig-Jove, C; Puig-Domingo, M; Groop, PH; Fernandez, E; Alonso, N; Mauricio, D

    Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease

    Cardiovascular Diabetology 18 93-93. .

    [doi:10.1186/s12933-019-0897-y]

  • Bermudez-Lopez M; Forne C; Amigo N; Bozic M; Arroyo D; Bretones T; Alonso N; Cambray S; Del Pino MD; Mauricio D; Gorriz JL; Fernandez E; Valdivielso JM

    An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients

    Expert Opinion On Therapeutic Targets 23 619-630. .

    [doi:10.1080/14728222.2019.1620206]

  • Bozic, M; Caus, M; Rodrigues-Diez, RR; Ruiz-Ortega, M; Martinez, A; Blasco, A; Gallel, P; Fernandez, E; Valdivielso, JM

    ALPHA-SYNUCLEIN MAINTAINS THE EPITHELIAL PHENOTYPE AND PROTECTS FROM RENAL FIBROSIS

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 156-156. .

  • Caus, M; Bozic, M; Fernandez, E; Valdivielso, JM

    ABSENCE OF VDR SOLELY IN VSMCS IMPEDES ARTERIAL CALCIFICATION IN CKD THROUGH TARGETING MIR-145A AND MIR-155

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 190-190. .

  • Cambray, S; Galimudi, RK; Bozic, M; Bermudez-Lopez, M; Rodriguez, I; Valdivielso, JM

    A The rs1126616 Single Nucleotide Polymorphism of the Osteopontin Gene Is Independently Associated with Cardiovascular Events in a Chronic Kidney Disease Cohort

    Journal of Clinical Medicine 8 -. .

    [doi:10.3390/jcm8050592]

  • Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project

    Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project

    Journal of Atherosclerosis and Thrombosis 26 879-889. .

    [doi:10.5551/jat.47498]

  • Valls J; Cambray S; Pérez-Guallar C; Bozic M; Bermúdez-López M; Fernández E; Betriu À; Rodríguez I; Valdivielso JM

    Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort

    Frontiers in Genetics 10 118-118. .

    [doi:10.3389/fgene.2019.00118]

  • Ferro CJ; Mark PB; Kanbay M; Sarafidis P; Heine GH; Rossignol P; Massy ZA; Mallamaci F; Valdivielso JM; Malyszko J; Verhaar MC; Ekart R; Vanholder R; London G; Ortiz A; Zoccali C

    Lipid management in patients with chronic kidney disease (vol 14, pg 727, 2018)

    NATURE REVIEWS NEPHROLOGY 15 121-121. .

    [doi:10.1038/s41581-018-0099-y]

Projectes

  • Calprotectin as a new companion biomarker and associated drug target for premature vascular aging in chronic kidney disease and type 2 diabetes
  • Papel de la señalizacion renal por IGF en los eventos tempranos de la enfermedad renal crónica
  • Crosstalk between vascular vitamin D signaling and bone homeostasis in CKD. Implications in mineral metabolism.
  • Estancias de personal docente y/o investigador senior en centros extranjeros 2022
  • El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • SPAIN CKD CAUSE (SPACKDC)
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • INVESTIGO 2022: Grup de recerca translacional vascular i renal
  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell